Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Regadenoson Monohydrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,698,640Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Adenoscan/Lexiscan

    02 2Lexiscan

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Lexiscan

    Regadenoson

    arrow
    Organic Process R&D
    Not Confirmed

    Brand Name : Lexiscan

    Japan
    arrow
    Organic Process R&D
    Not Confirmed

    Astellas

    Regadenoson

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2021 Revenue in Millions : 769

    2020 Revenue in Millions : 542

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Lexiscan

    Regadenoson

    arrow
    OPRD
    Not Confirmed

    Brand Name : Lexiscan

    Japan
    arrow
    OPRD
    Not Confirmed

    Astellas

    Regadenoson

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 719

    2021 Revenue in Millions : 768

    Growth (%) : -6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Adenoscan/Lexiscan

    Adenosine, Regadenoson

    arrow
    OPRD
    Not Confirmed

    Brand Name : Adenoscan/Lexiscan

    Japan
    arrow
    OPRD
    Not Confirmed

    Astellas

    Adenosine, Regadenoson

    Main Therapeutic Indication : Diagnostic

    Currency : USD

    2018 Revenue in Millions : 681

    2017 Revenue in Millions : 628

    Growth (%) : 9%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Adenoscan/Lexiscan

    Adenosine, Regadenoson

    arrow
    OPRD
    Not Confirmed

    Brand Name : Adenoscan/Lexiscan

    Japan
    arrow
    OPRD
    Not Confirmed

    Astellas

    Adenosine, Regadenoson

    Main Therapeutic Indication : Diagnostic

    Currency : USD

    2016 Revenue in Millions : 629

    2015 Revenue in Millions : 682

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Adenoscan/Lexiscan

    Adenosine, Regadenoson

    arrow
    OPRD
    Not Confirmed

    Brand Name : Adenoscan/Lexiscan

    Japan
    arrow
    OPRD
    Not Confirmed

    Astellas Pharma

    Adenosine, Regadenoson

    Main Therapeutic Indication : Diagnostic

    Currency : USD

    2017 Revenue in Millions : 670

    2016 Revenue in Millions : 671

    Growth (%) : -0.2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF